Man with life-threatening peanut allergy now eats them every day thanks to study
A man with a life-threatening peanut allergy is able to eat several per day thanks to a "ground-breaking" study.
Richard Lassiter, 44, says he has been admitted to hospital twice due to his severe nut allergy, but now eats four peanuts every morning as part of a trial which has seen him gradually increase his exposure to them.
One of his reactions came during a holiday in Chile with his wife in 2018, when he had a reaction so bad he had to stay in a high dependency unit overnight and have adrenaline and oxygen.
He is one of 21 people between the ages of 18 and 40 who took part in the research conducted by King's College London and Guy's and St Thomas' NHS Foundation Trust.
The study was the first entirely on adults with severe allergies to test whether daily doses of peanuts taken under strict supervision can be safely tolerated.
Other "desensitisation" studies are focused on children, the experts say, meaning adults don't get the opportunity to counter their allergies.
The study, called The Grown Up Peanut Immunotherapy trial, saw participants with allergies slowly increase their daily dosage from 0.8mg peanut flour mixed in with food.
Once they could tolerate 50-100mg of peanut protein, they were switched to eating whole peanuts, peanut butter or other peanut products.
By the end of the study, which was funded by the National Institute for Health and Care Research, two thirds were able to eat the equivalent of five peanuts without reacting.
Speaking to Sky's Wilfred Frost, Mr Lassiter said: "There was definitely a sense of nerves at first. You know, you have to get your mind around the idea of eating something you've tried to avoid your whole life.
"But I think at the point that I found out about the trial, it was something I was really keen to do. I obviously had a couple of [dangerous] incidents reasonably fresh in my mind."
He said the trial had changed his life, adding that he took the nuts like "medicine".
"The idea that I take four peanuts a day now after my breakfast is well-worn routine," he said.
"I know it's something I'll do for the rest of the rest of my life.
"I'm certainly much more confident and calm when I go out to dinner with my wife, or when we go travelling. I know that that accidental exposure to peanuts isn't going to cause a serious reaction like it has done in the past."
Read more:
He added that he knew it still wasn't safe to order a meal with a strong presence of nuts.
Chief investigator Stephen Till, professor of allergy at King's College London and consultant allergist at Guy's and St Thomas', told Sky News the trial provided hope for those with nut allergies, but was definitely "not something to do at home".
He said the next step would be to conduct larger trials and identify "the group of adult patients who would most likely benefit from oral immunotherapy, and see whether it can lead to long-term tolerance in this age group".
Asked if such trials could potentially benefit people with other types of allergies, Prof Till said: "Potentially, yes. The principle should be applicable to other food options, but what I would say is that different foods can behave differently in terms of the amounts that are required to cause reactions and how severe the reactions are. So to do it in other foods, you really do need to do trials for those specific foods individually."
Public health minister Ashley Dalton said: "This ground-breaking research offers hope to thousands living with peanut allergies. For too long, people have navigated daily life in fear of accidental exposure that could be life-threatening.
"I'm proud the UK is leading this vital work through NIHR funding. These results show how we're transforming lives through science, potentially changing care standards for adults with peanut allergies worldwide."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
ADHD is not really on the rise, study suggests
ADHD is not rising despite public perception that cases are increasing, a study suggests. Researchers at King's College London found little evidence to suggest that the prevalence of attention deficit hyperactivity disorder was getting worse, and said many studies suggesting an increase were of too low quality to be trusted. Dr Alex Martin, lecturer in psychology at King's, said: 'The media has been concerned about a 'surge' in ADHD diagnoses for several years. 'While assessments and help-seeking may be increasing, our study has shown significant gaps in the tracking of ADHD prevalence, resulting in a frustratingly unclear picture. 'The best data we have suggests that there has been no meaningful increase in ADHD prevalence, but most of the research is too biased to draw conclusions from.' Anecdotal reports suggest that the UK has had an unprecedented rise in the number of children and adults seeking support for ADHD, with significant backlogs of people currently awaiting assessment. The demand for ADHD diagnoses has exacerbated pressures on the NHS, with a survey by the Pensions Committee in 2023 finding that about one in four people faced delays of two years while one in 10 waited 10 years for an assessment. There were fears that the Covid pandemic and social media may have exacerbated the problem, with many more youngsters experiencing mental health issues during lockdowns. But while calls for assessments are growing, there is little evidence to suggest it was leading to a rise in the overall prevalence of the condition, the study found. The team discovered that studies suggesting ADHD rates were rising were of low quality, using self-reporting surveys, or reported symptoms from parents and teachers, rather than actual clinical diagnoses. Researchers said that the demand for assessments might be driven by increased awareness, rather than more cases. Between January and May last year, there were 25,080 media articles published on ADHD compared with 5,775 articles in the same period in 2014. The growth of the 'neurodiversity movement' may also have played a role in raising the profile of the condition and encouraging more people to seek help. Edmund Sonuga-Barke, professor of developmental psychology at King's, said: 'The neurodiversity movement, with its concentration on personal lived experience and self-compassion as the ultimate reference point for decision-making, is likely driving cultural change. 'In this regard, it's potentially increasing rates of self-referral among adolescents and adults.' In the UK, it's estimated that ADHD affects about 3-5 per cent of children and adults. The US has far higher rates, with nearly 12 per cent of youngsters diagnosed with the condition. This has led to a crackdown by the Trump administration on over-prescribing of ADHD drugs to youngsters. Prof Sonuga-Barke said US and UK rates were likely to be similar and he agreed there should be an investigation. 'I think the prevalence of ADHD is very similar in the US and the UK,' he said. 'I think there's grounds for an investigation to the impact of the prescriptive prescribing rates in the States.' A recent BBC investigation suggested that at least 196,000 adults were on NHS waiting lists for ADHD researchers said that greater awareness of the condition might also mean that young people are now using the term ADHD as 'language of distress', to signal they are struggling, even though they do not have the condition. Prof Phillip Shaw, director of the King's Maudsley Partnership for Children and Young People at King's, said: 'There's both an increased recognition and less stigma around ADHD, which means that people are increasingly coming forward for assessment. 'My hunch is that there's such a huge awareness of ADHD that it's often used as a language of distress. 'It's sometimes used, I suspect, by young people who are expressing that they are struggling, particularly at school, and need help.' This study was funded by NHS England and was conducted by the NIHR Health Protection Research Unit in Emergency Preparedness and Response. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Yahoo
a day ago
- Yahoo
Greater awareness not more cases behind ADHD surge, study suggests
ADHD is not becoming more common despite the surge in people being diagnosed, research suggests. The review, led by King's College London, looked at 40 studies in 17 countries and found no clear evidence rates of attention deficit hyperactivity disorder (ADHD) had risen since 2020, despite rising diagnoses and longer waits for assessment. Some blame greater social media use and the Covid pandemic for rising numbers developing the condition - but the researchers say greater awareness and acceptance were likely to be encouraging more people to seek help. There were no signs the true rate of ADHD, known as prevalence, was on the up, they added. Lead researcher Dr Alex Martin said it was likely to be a case of under-diagnosis of the condition in the first place. "ADHD prevalence in adults and children has remained largely stable since 2020," she added. In the UK, around 3 to 4% of adults and around 5% of children and young people are thought to have ADHD. Experts believe there are similar rates in other countries but only a fraction of these have been diagnosed. ADHD is a neurodevelopmental condition characterised by difficulties with concentration, energy levels, impulsiveness, or by a person's ability to manage their time. The study, published in the Journal of Affective Disorders, comes as a national taskforce in England is looking at what this rising demand for support means across the NHS, education and justice sectors. Figures published last week by NHS England estimated there were nearly 2.5 million people in England with ADHD, with more than 550,000 currently waiting for an assessment. Every month 20,000 more people are referred for support, a 13% rise on this time last year. NHS England has admitted patients are waiting "too long for assessment and diagnosis". Patient watchdog Healthwatch England has also campaigned on the issue, calling for better support. A report it published last week highlighted how ADHD can lead to people struggling in work and education and emphasised the importance of them getting a diagnosis to help understand and manage their condition. One woman, Alex, told the watchdog a diagnosis had helped her find ways to manage better and opened up access to medication which meant she was better able to care for her daughter. "I just couldn't cope with normal things or keep a routine. It made living exhausting." But the 32-year-old was only able to get a diagnosis after paying for private support. "I'm lucky I could afford going private, but I know many people can't," she added. Henry Shelford, of ADHD UK, said the condition had been ignored for too long. "Increasing awareness and diagnosis is the key to unlocking the talents of over 2 million people in the UK. "Doing so isn't just good for the individual, it's economically positive for the entire country." Prof Edmund Sonuga-Barke, a fellow at the Academy of Medical Sciences and an ADHD expert at King's College London who was not involved in the research, said it was clear there had been a "chronic under-diagnosis" of ADHD in the UK. He said while ADHD medications were safe, there needed to be more progress in developing a greater range of non-drug treatments and therapies to help people self-manage their conditions. It comes amid criticism too many people are being placed on drugs to treat ADHD.
Yahoo
2 days ago
- Yahoo
Women less likely to get care for potentially fatal heart condition, study finds
Women are less likely than men to be given treatment for a potentially fatal heart condition, according to a new analysis. Researchers found women are 11% less likely to be referred to a hospital specialist after a diagnosis of the heart valve disease aortic stenosis. Academics said the findings show 'inequities in management and care of this common and serious condition' after they also found differences in care among south Asian and black patients as well as those from poorer backgrounds. Aortic stenosis, a narrowing of the aortic valve or the area immediately around it, leads to obstruction of the blood flow from the heart, which leads to symptoms including dizziness, fatigue, chest pain and breathlessness. The condition is more common in elderly people. It is not possible to reverse but treatments can include a transcatheter aortic valve implantation (TAVI) or valve replacement surgery. If left untreated it can lead to serious complications, including heart failure, heart rhythm abnormalities, and death. The analysis suggests some people are less likely to receive this treatment. Experts from the University of Leicester examined GP data on 155,000 people diagnosed with aortic stenosis between 2000 and 2022 in England. Presenting their findings to the British Cardiovascular Society conference in Manchester, experts said as well as women being less likely to be referred for hospital care, they are 39% less likely to have a procedure to replace their aortic valve. Researchers also found people living in poorer neighbourhoods are 7% less likely to be referred for hospital care after a diagnosis compared to people from wealthier neighbourhoods. Meanwhile, black patients are 48% less likely to undergo a procedure to replace their aortic valve compared to white patients. South Asian patients are 27% less likely to undergo a procedure compared to their white counterparts, according to the study, which was funded by the National Institute for Health and Care Research (NIHR) and supported by NIHR Leicester Biomedical Research Centre. Dr Anvesha Singh, associate professor at the University of Leicester and consultant cardiologist, who was involved in the research, said: 'Previous studies have shown lower rates of valve replacement in women, and clinicians had assumed that women were less likely to be diagnosed with aortic stenosis. 'This analysis using large, real-world data clearly shows that this is not the case, giving us the clearest picture yet of what is happening in day-to-day clinical practice. 'Our study highlights potential inequities in management and care of this common and serious condition. More research is needed to understand the reasons for this and the true prevalence of aortic stenosis in different groups.' Dr Sonya Babu-Narayan, clinical director at the British Heart Foundation, which supported the research, and consultant cardiologist, said: 'This study of over 150,000 GP records has unveiled disparities in access to aortic valve treatment for women, south Asian and black people, and people living in more deprived communities. 'We don't yet have the full picture, but these findings are concerning and we need more research to understand what is driving the differences seen. 'This will be crucial to enable action to address any underlying causes stopping some people from having access to the heart valve treatment and care they need, when they need it.'
